Host Andrew Cohen, MD, speaks with medical historian Steven Peitzman, MD, on the birth of nephrology, a specialty that was not formally recognized until the mid-twentieth century.

Host Andrew Cohen, MD, discusses the advent of recombinant erythropoietin (rEPO) and its impact on kidney care with Paul Kimmel, MD, FASN; Daniel Coyne, MD; and Ajay Singh, MD.

Alice Sheridan, MD, FASN, and Martina McGrath, MD, FASN, speak with guest editors Sankar D. Navaneethan, MD, MS, MPH, and Garabed Eknoyan, MD, to discuss their editorial "ESKD: A Therapeutic Triumph of Nephrology" from nephSAP Volume 24, Number 4, ESKD.

Hosts Tod Ibrahim, ASN Executive Vice President and David White, Senior Quality & Regulatory Affairs Officer are joined by Lauren Ahearn, Senior Quality & Regulatory Affairs Associate to discuss the most recent spending package passed by Congress.

Kidney Week 2025 may be coming to a close, but the conversation continues. Hear Meg Jardine, MBBS, PhD, Vineeta Kumar, MD, FASN, and Robert A. Montgomery, MD, PhD, explore research trials and developments in transplant nephrology.

Listen as Matthias Kretzler, MD, Julio Saez-Rodriguez, PhD, and Katalin Susztak, MD, PhD, discuss advancements and challenges in research during the episode "Future Therapies: Science Shaping Tomorrow's Kidney Care."

Kidney Week has begun. Listen as Hiddo Jan L. Heerspink, PhD, Julie R. Ingelfinger, MD, and Richard A. Lafayette, MD, explore the impact this year's late-breaking clinical trials will have on nephrology.

ASN Executive Vice President and host Tod Ibrahim examines the obstacles early advocates overcame to secure financial coverage for dialysis for Americans living with kidney failure, with guests Charles "Chip" Kahn III, Terry Litchfield, and C.J. Blagg.

With the government officially closed, hosts Tod Ibrahim and David White explore how the shutdown affects federal health agencies, including HHS, NIH, and the VA.

Host Tod Ibrahim speaks with Ryan Murray, ASN Senior Manager of Government Affairs, about ASN's advocacy on recent NIH policy changes, the society's statement to the Senate Finance Committee, and its partnership with Research!America.